ERN1 and neoplasm: This anti-tumoral effect is attributed to the RNAse activity of IRE1α, which induces apoptosis in tumor cells, enhances adaptive anti-cancer immunosurveillance through XBP1 mRNA splicing, and regulates IRE1-dependent degradation of RNA (RIDD) (Martinez-Turtos et al., 2022).